System Transmission

Top Signal

100#1 JOB

Activity

2180Ripe

+936 today

System

Livenow

Terminal Asset View

stockNASDAQ

BTAI

$1.49-3.87%

BioXcel Therapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

31Overripe

Live Analysis Active

Company Mission

BioXcel Therapeutics develops medicines for brain-related conditions like agitation in dementia and schizophrenia. Doctors prescribe these drugs to patients who need help managing symptoms of these disorders. The company makes money by selling these approved medications and through partnerships with larger pharmaceutical companies that help develop and market their drugs.

BTA

Industry Context

The biotech industry focuses on developing new medical treatments through scientific research. Companies in this space often see big stock price swings based on news about their drug trials, regulatory approvals, or partnerships. BioXcel operates in this high-risk, high-reward environment where successful drug development can lead to substantial value creation.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

81Matrix

Market Momentum

42.8— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.2x— Normal Volume

Today's Change

-3.87%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BTAI across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 11:00 PM UTC

As-of 03-14-2026 22:45 UTC

Develops drugs for brain disorders and sells them to hospitals and pharmacies after clinical trials prove they work.

Technical squeeze detected, suggesting price may be ready for a significant move as buying and selling pressure builds to a tipping point showing showing consolidation pattern.

Biotech sector volatility creates opportunities for clinical-stage companies, with investors watching for trial results that can dramatically shift, suggesting dramatically shift.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...